Our previous study showed that CGA improved obesity-related metabolic disorders by upregulating Pparg2 expression and inhibiting the nuclear factor (NF)-κB-signaling pathway in the adipose tissue of obese rats induced by a HFD [17]. This evidence concerns the gene PPARG and metabolic disease.